Abstract: The present invention relates generally to the field of the LC-PUFA containing compositions. For example, the present invention relates to at least partially preventing, inhibiting, reducing and/or stopping the oxidation of LC-PUFA in a composition. An embodiment of the present invention relates to a composition comprising at least one LC-PUFA containing oil and Glycyrrhiza, a part and/or an extract thereof. Another embodiment of the present invention relates to the use of Glycyrrhiza, a part and/or an extract thereof in compositions comprising an LC-PUFA containing oil to at least partially prevent, inhibit, reduce and/or stop the oxidation of LC-PUFA in the composition.

Abstract: The present invention concerns an enzymatic process for the preparation of a triglyceride ingredient comprising triglycerides present in human breast milk.

Abstract: A maternal supplement or human milk fortifier composition comprising at least one nutrientselected in the list consisting of: ALA, DHA, EPA, vitamin A, thiamine, thiamine monophosphate, vitamin B2, vitamin B6, vitamin B9, calcium and phosphorus, GD3, GM3. Said maternal supplement or human milk fortifier composition is specifically tailored or adapted for a woman who has delivered via C-section who is breast feeding. Said maternal supplement or human milk fortifier composition is beneficial to provide adequate nutrition to a woman who has delivered via C-section and promote associated health benefits.

Abstract: A paediatric supplement or human milk fortifier composition comprising at least one nutrients selected in the list consisting of: ALA, DHA, EPA, 2FL, LNnT, vitamin A, thiamine, thiamine monophosphate, vitamin B2, vitamin B6, vitamin B9, calcium and phosphorus, GD3, GM3. Said paediatric supplement or human milk fortifier composition is tailored or adapted for a child born via C-section who is breast fed and/or to fortify the breast milk of a woman who has given birth via C-section. Said paediatric supplement or human milk fortifier composition is beneficial to provide adequate nutrition to a child born via C-section and promote associated health benefits.

Abstract: A paediatric supplement or human milk fortifier composition comprising at least one nutrient selected in the list consisting of: ALA, DHA, EPA, 2?FL, LNnT, vitamin A, thiamine, thiamine monophosphate, vitamin B2, vitamin B6, vitamin B9, calcium and phosphorus, GD3, GM3. Said paediatric supplement or human milk fortifier composition is tailored or adapted for an infant born via C-section who is breast fed and/or to fortify the breast milk of a woman who has given birth via C-section. Said paediatric supplement or human milk fortifier composition is beneficial to prevent nutrition inadequacy an infant born via C-section and promote associated health benefits.

Abstract: Use of an ?-lactalbumin enriched whey protein extract as a source of sphingomyelin in a synthetic nutritional composition for an infant or child wherein, the ?-lactalbumin enriched WPE is obtained by a process comprising: a. acidifying a whey protein product to pH 4 or below b. forming a low calcium whey protein product by concentrating the proteins in the acidified whey protein until the calcium to protein ratio is less than about 0.001 and, c. Precipitating ?-lactalbumin from the low-calcium whey protein product, wherein said precipitating step includes the sub-steps of: I. diluting the low-calcium whey protein product, II. adjusting the pH of the diluted low-calcium whey protein product to between 4 and 5 to form a precipitate and soluble proteins, and III. Separating the precipitate proteins from the soluble proteins.

Abstract: Synthetic nutritional formulations, particularly milk based compositions, for infants and children are especially adapted to the age of the child. They are adapted to fulfill the nutritional needs of the child, ensuring balanced growth and development and thereby reducing the risk of obesity.

Abstract: The present invention concerns an enzymatic process for the preparation of a triglyceride ingredient comprising triglycerides present in human breast milk.

Abstract: The present invention relates generally to the field of the LC-PUFA containing compositions. For example, the present invention relates to at least partially preventing, inhibiting, reducing and/or stopping the oxidation of LC-PUFA in a composition. An embodiment of the present invention relates to a composition comprising at least one LC-PUFA containing oil and Glycyrrhiza, a part and/or an extract thereof. Another embodiment of the present invention relates to the use of Glycyrrhiza, a part and/or an extract thereof in compositions comprising an LC-PUFA containing oil to at least partially prevent, inhibit, reduce and/or stop the oxidation of LC-PUFA in the composition.

Abstract: Synthetic nutritional formulations, particularly milk based compositions, for infants and children are especially adapted to the age of the child. They are adapted to fulfill the nutritional needs of the child, ensuring balanced growth and development and thereby reducing the risk of obesity.

Abstract: The invention concerns synthetic nutritional formulations, particularly milk based compositions, for infants and children. The compositions are especially adapted to the age of the child. They are adapted to fulfill the nutritional needs of the child, ensuring balanced growth and development and thereby reducing the risk of obesity.

Abstract: The invention concerns synthetic nutritional formulations, particularly milk based compositions, for infants and children. The compositions are especially adapted to the age of the child, younger or older than three months. The invention further relates to administration of these compositions for promoting the healthy establishment of cognitive function in infant boys and girls and in young boys and girls up to the age of thirty-six months.

Abstract: Synthetic nutritional compositions for infants and young children up to the age of thirty-six months, particularly infant formulae and growing-up milks, vary according to gender and the age of the infant or young child. The compositions have been designed to ensure balanced growth and to prevent obesity in in-fancy and later in life.

Abstract: The present invention concerns a highly selective process for the preparation of an ingredient comprising 1,3-Olein-2-palmitin (OPO), a triglyceride present in human breast milk. The present invention also relates to 1,3-Olein-2-palmitin (OPO) ingredient obtainable by the process.

Abstract: Synthetic nutritional compositions tailored for infants of specific ages comprising Lutein in concentrations reflecting those found in human milk produced for infants of the same age (at the corresponding lactation stage), and nutritional systems comprising them.

Abstract: Gender specific synthetic nutritional compositions comprising lutein in concentrations reflecting those found in human milk produced by mothers of infants of the corresponding gender at the corresponding age/stage of lactation, and nutritional systems comprising them.

Abstract: Gender specific synthetic nutritional compositions comprising lycopene in concentrations reflecting those found in human milk produced by mothers of infants of the corresponding gender at the corresponding stage of lactation, and nutritional systems comprising them.

Abstract: Synthetic nutritional compositions tailored for infants of specific ages comprising Lycopene in concentrations reflecting those found in human milk produced for infants of the same age, and nutritional systems comprising them.

Abstract: Use of an ?-lactalbumin enriched whey protein extract as a source of sphingomyelin in a synthetic nutritional composition for an infant or child wherein, the ?-lactalbumin enriched WPE is obtained by a process comprising: a. acidifying a whey protein product to pH 4 or below b. forming a low calcium whey protein product by concentrating the proteins in the acidified whey protein until the calcium to protein ratio is less than about 0.001 and, c. Precipitating ?-lactalbumin from the low-calcium whey protein product, wherein said precipitating step includes the sub-steps of: I. diluting the low-calcium whey protein product, II. adjusting the pH of the diluted low-calcium whey protein product to between 4 and 5 to form a precipitate and soluble proteins, and III. Separating the precipitate proteins from the soluble proteins.

Abstract: Synthetic nutritional compositions tailored for infants of specific ages comprising cholesterol in concentrations reflecting those found in human milk produced for infants of the same specific ages, and nutritional systems comprising them.